Vertex Pharmaceuticals Incorporated VRTX
536.26 USD +5.50 (+1.04%)
Nov 4, 2026, 9:33 AM EST
534.01 Day range 540.69
409.47 52-week range 558.88
- YTD
- +18.29%
- 1 year
- +27.18%
Revenue & Expenses
Revenue by
Latest period ending Dec 31, 2025 · select a line to chart its full history
Annual income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 12.00B | 11.02B | 9.87B | 8.93B | 7.57B | |
| 12.00B | 11.02B | 9.87B | 8.93B | 7.57B | |
| 1.65B | 1.53B | 1.26B | 1.08B | 904.20M | |
| 10.35B | 9.49B | 8.61B | 7.85B | 6.67B | |
| 6.17B | 9.72B | 4.83B | 3.60B | 3.89B | |
| 3.91B | 3.63B | 3.16B | 2.54B | 1.94B | |
| 1.75B | 1.46B | 1.14B | 944.70M | 840.10M | |
| 4.18B | -233.40M | 3.78B | 4.25B | 2.78B | |
| 13.30M | 30.60M | 44.10M | 54.80M | 61.50M | |
| 690.00M | 784.10M | 760.20M | 910.40M | 388.30M | |
| 3.95B | -535.60M | 3.62B | 3.32B | 2.34B | |
| 3.95B | -535.60M | 3.62B | 3.32B | 2.34B | |
| 3.95B | -535.60M | 3.62B | 3.32B | 2.34B | |
| 3.95B | -535.60M | 3.62B | 3.32B | 2.34B | |
| 15.46 | -2.08 | 14.05 | 12.97 | 9.09 | |
| 15.46 | -2.08 | 14.05 | 12.97 | 9.09 | |
| 15.32 | -2.08 | 13.89 | 12.82 | 9.01 | |
| 4.66B | 279.10M | 4.42B | 4.29B | 2.79B | |
| 4.66B | 279.10M | 4.42B | 4.29B | 2.79B | |
| 255.70M | 257.90M | 257.70M | 256.10M | 257.70M | |
| 258.00M | 257.90M | 260.50M | 259.10M | 259.90M |